BioMarin Pharmaceutical takes decisive strides toward environmental stewardship by integrating sustainable strategies across its operations, encompassing energy-efficient manufacturing, responsible supply chain management, waste reduction initiatives, and sustainable packaging solutions, all strategically aimed at reducing its ecological footprint and promoting a culture of environmental responsibility that echoes its core mission of contributing to a healthier planet.A vanguard of positive social impact, BioMarin Pharmaceutical elevates its role in transforming lives through rare disease therapies, channeling its innovative product portfolio toward addressing unmet medical needs, while actively engaging in patient support initiatives, community collaborations, and healthcare education programs, thus fostering a holistic and meaningful approach to societal well-being. BioMarin Pharmaceutical’s unwavering commitment to research excellence and innovation underpins its ESG sustainability strategy, as it persistently advances pioneering therapies that address rare diseases, improve patient outcomes, and drive medical science forward, all while maintaining a steadfast adherence to the highest ethical standards, research integrity, and a patient-centric ethos that underscores its pivotal role in transforming healthcare landscapes.The bedrock of BioMarin Pharmaceutical’s ESG framework rests upon a foundation of exemplary governance practices, underscored by a culture of transparency, integrity, and accountability that permeates its decision-making processes, facilitated by a diverse and experienced board of directors, rigorous compliance protocols, and ethical conduct that positions the company as a model of responsible corporate leadership.BioMarin Pharmaceutical’s financial sustainability harmoniously intertwines with its ESG imperatives, as its financial growth is inextricably linked to its ability to develop and provide groundbreaking rare disease treatments that resonate with patients, healthcare professionals, and investors who recognize the inherent value of responsible innovation and sustainable business practices. BioMarin Pharmaceutical’s stakeholder engagement philosophy thrives on inclusivity and collaboration, extending to patients, healthcare professionals, employees, communities, and investors, fostering an environment of open dialogue, attentive listening, and transparent communication that shapes its strategies, aligns with societal aspirations, and underscores its unwavering dedication to advancing healthcare and societal well-being.BioMarin Pharmaceutical Inc., an innovative and forward-looking biopharmaceutical company renowned for its steadfast commitment to rare disease therapies, epitomizes an all-encompassing dedication to ESG (Environment, Social, Governance) sustainability that intricately weaves through the fabric of its operations, showcasing its unwavering ethical compass, positive societal impact, and enduring value creation, while remaining resolutely aligned with the diverse needs of patients, healthcare partners, and global stakeholders, thereby exemplifying a profound and responsible approach to pioneering advancements in rare disease treatment through sustainable business practices.